Literature DB >> 9515793

Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.

S A Hahn1, D Bartsch, A Schroers, H Galehdari, M Becker, A Ramaswamy, I Schwarte-Waldhoff, H Maschek, W Schmiegel.   

Abstract

A candidate tumor suppressor gene, DPC4, located at 18q21.1, has recently been shown to be inactivated in half of pancreatic adenocarcinomas. The close developmental relationship of the pancreas and biliary tract prompted us to determine the role of DPC4 in the multistep carcinogenesis of biliary tract carcinoma. A search for mutations in the genomic sequence of the highly conserved COOH-terminal domain of DPC4 (exons 8-11) was performed by single-strand conformational polymorphism analysis. Five of 32 (16%) primary biliary tract carcinomas had point mutations in the DPC4 sequence. Interestingly, inactivation of DPC4 was especially common in carcinomas originating from the common bile duct (four of eight specimens analyzed), suggesting an important role for DPC4 in the development of this subtype of biliary tract tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515793

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells.

Authors:  T A Sohn; G H Su; B Ryu; C J Yeo; S E Kern
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

Review 2.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

3.  Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice.

Authors:  Chiara Gabbi; Hyun-Jin Kim; Rodrigo Barros; Marion Korach-Andrè; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

4.  Immunohistochemical study of DPC4 and p53 proteins in gallbladder and bile duct cancers.

Authors:  Shih-Chang Chuang; King-Teh Lee; Kun-Bow Tsai; Pai-Ching Sheen; Eishi Nagai; Kazuhiro Mizumoto; Masao Tanaka
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

5.  G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.

Authors:  J L Dai; R K Bansal; S E Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

6.  Effect of transforming growth factor-beta1 on human intrahepatic cholangiocarcinoma cell growth.

Authors:  Tetsuya Shimizu; Shigeki Yokomuro; Yoshiaki Mizuguchi; Yutaka Kawahigashi; Yasuo Arima; Nobuhiko Taniai; Yasuhiro Mamada; Hiroshi Yoshida; Koho Akimaru; Takashi Tajiri
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

Review 7.  Pancreatic carcinogenesis.

Authors:  Jan-Bart M Koorstra; Steven R Hustinx; G Johan A Offerhaus; Anirban Maitra
Journal:  Pancreatology       Date:  2008-04-01       Impact factor: 3.996

8.  Loss of DPC4 expression and its correlation with clinicopathological parameters in pancreatic carcinoma.

Authors:  Zhan Hua; Yuan-Chun Zhang; Xiao-Ming Hu; Zhen-Geng Jia
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

Review 9.  Current research in perineural invasion of cholangiocarcinoma.

Authors:  Fang-Zhen Shen; Bing-Yuan Zhang; Yu-Jie Feng; Zhuo-Xia Jia; Bing An; Chang-Chang Liu; Xi-Yun Deng; Anil D Kulkarni; Yun Lu
Journal:  J Exp Clin Cancer Res       Date:  2010-03-10

10.  Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer.

Authors:  C Mamot; G Mild; J Reuter; U Laffer; U Metzger; L Terracciano; J-L Boulay; R Herrmann; C Rochlitz
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.